Quick10K

⚲

PlayAGS

Filings

10-Q	2021-03-31	Filed 2021-05-06
10-K	2020-12-31	Filed 2021-03-04
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-05
10-Q	2020-03-31	Filed 2020-05-07
10-K	2019-12-31	Filed 2020-03-04
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-07
10-Q	2019-03-31	Filed 2019-05-08
10-K	2018-12-31	Filed 2019-03-05
10-Q	2018-09-30	Filed 2018-11-08
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-03
10-K	2017-12-31	Filed 2018-03-14
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-10
10-K	2016-12-31	Filed 2017-03-10
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-15
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-03-10
10-Q	2015-09-30	Filed 2015-11-16
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-03-31
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-19
10-Q	2014-03-31	Filed 2014-05-15
10-K	2013-12-31	Filed 2014-03-31

Reports

8-K	2020-11-05
8-K	2020-09-14
8-K	2020-08-05
8-K	2020-07-01
8-K	2020-05-07
8-K	2020-05-01
8-K	2020-04-21
8-K	2020-04-13
8-K	2020-04-06
8-K	2020-03-19
8-K	2020-03-17
8-K	2020-03-04
8-K	2019-11-07
8-K	2019-09-10
8-K	2019-08-30
8-K	2019-08-12
8-K	2019-08-07
8-K	2019-07-25
8-K	2019-06-20
8-K	2019-05-08
8-K	2019-05-08
8-K	2019-03-21
8-K	2019-03-19
8-K	2019-03-18
8-K	2019-03-05
8-K	2019-02-11
8-K	2018-12-17
8-K	2018-12-14
8-K	2018-11-08
8-K	2018-10-05
8-K	2018-10-03
8-K	2018-09-24
8-K	2018-09-19
8-K	2018-08-13
8-K	2018-08-08
8-K	2018-08-06
8-K	2018-08-02
8-K	2018-05-15
8-K	2018-05-09
8-K	2018-05-07
8-K	2018-05-03
8-K	2018-03-20
8-K	2018-03-14
8-K	2018-02-27
8-K	2018-02-07
8-K	2018-01-31
8-K	2018-01-30
8-K	2018-01-30

PlayAGS Financials

AGS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash						49	39	26	29	28	23	18	8	23	10	19	26	28	33	71	10	18	12
Accounts Receivable						22	20		24	25	23	24	24	25	34	33	39	45	46	45	50	50	58
Inventory						7	7		7	8	9	11	12	13	19	24	29	30	32	27	28	30	30
PP&E	49	46	44	41	41	72	68	67	65	62	64	68	71	77	75	78	81	81	84	92	108	103	105
Assets						780	756	233	687	667	648	634	617	633	640	697	702	703	706	731	765	762	760
Accounts Payable	1	1	2	1	1	3	6	5	4	5	6	9	6	8	10	11	12	12	12	15	18	14	19
Long-Term Debt	157	168	168	170	170	542	538	562	540	547	547	572	558	588	603	676	508	517	513	539	537	536	532
Liabilities						646	645	133	607	608	611	618	612	648	659	725	556	564	560	596	627	628	633
Stockholders' Equity						135	111	101	80	59	37	16	5	-15	-19	-28	146	139	146	136	138	133	127


Income Statement ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue						26	38		40	43	41	43	48	50	56	58	65	73	76	72	73	75	79
Cost of Revenue						6	7		6	7	7	7	7	7	7	10	9	10	10	21	10
Gross Profit						21	31		34	36	34	36	40	43	49	42	56	63	65	51	63
R&D	1	0	0		1	3	5		5	5	7	5	5	6	6	8	9	7	8		8	8	9
SG&A						9	14	-28	13	11	13	9	10	10	10	14	17	15	15		15	15	17
Tax						-23	-7	25	0	-2	-1	2	2	1	1	0	0	7	-4		-6	-0	2
Net Income						3	-23	-9	-21	-19	-21	-20	-12	-20	-4	-9	-10	-5	4	-10	0	-7	-6


Cash Flow ($MM)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating							7	-6	5	10	10	9	7	11	8	18	-33	22	24		12	26	25
Cash Investing							-15	226	-8	-9	-12	-13	-14	-18	-17	-71	-15	-18	-16		-70	-15	-24
Cash Financing							-2	-230	-4	-3	-3	-2	-3	22	-4	63	54	-3	-2		-2	-3	-7